• Keywords
  • Category
    Search for category
      view more
    • Locations
      Search for locations
        • Bluebird Bio
        • Cambridge, MA, US
        • HQ
        • Cambridge, MA, US
        • Employees
        • 1,213
        • Scientist I/II, In Vivo Gene Editing

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Scientist I, Formulations

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Quality Training Specialist, Quality Assurance

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Director, Regulatory, Advertising and Promotion

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Computer System Validation Engineer (Contract)

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Clinical Trial Transparency - Lead (Contract)

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Senior Packaging Engineer

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Senior Associate Scientist I, Method Development and Qualification

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Head, US Field Medical

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Data Scientist I/II

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Associate Scientist II (Contract)

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        • Associate Scientist I (Contract)

          On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded…

        Load more

        Discover other companies

        Explore in-depth profiles of 30,000+ companies including metrics, people, jobs and more.

        Click To Explore
        Filter